Trexquant Investment »

Contineum Therapeutics shares owned by Trexquant Investment

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2025-09-30 $344k 29k 11.75

More positions owned by Trexquant Investment

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)
Apple (AAPL)
Amazon (AMZN)
Tesla Motors (TSLA)
Accenture Plc Ireland Shs Class A (ACN)
Palantir Technologies Cl A (PLTR)
Caterpillar (CAT)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
Honeywell International (HON)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
Comcast Corp Cl A (CMCSA)

View all positions for Trexquant Investment

Top funds holding Contineum Therapeutics

RA Capital Management
Johnson & Johnson
Suvretta Capital Management
Franklin Resources
Vanguard Group
Balyasny Asset Management
FMR
Sectoral Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management
Samsara BioCapital
Versant Venture Management
Point72 Asset Management

View all funds holding Contineum Therapeutics